{"id":"W2294307578","doi":"10.1093/annonc/mdw098","title":"Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"Translational Research in Oncology; Université Laval; Brampton Civic Hospital; Ontario Institute for Cancer Research","funders":"Pfizer; Halozyme; GlaxoSmithKline; Amgen","keywords":"Medicine; Docetaxel; Cyclophosphamide; Breast cancer; Regimen; Internal medicine; Febrile neutropenia; Oncology; Metastatic breast cancer; Chemotherapy; Neutropenia; Doxorubicin; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002129483,0.001845889,0.003117202,0.0003264896,0.0003933538,0.001256982,0.001190659,0.001579535,0.005253306],"category_scores_gemma":[0.001884874,0.0007236687,0.002764317,0.0004608026,0.00114894,0.001130281,0.0006050691,0.003866235,0.0009307093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001526872,"about_ca_system_score_gemma":0.001262335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00220158,"about_ca_topic_score_gemma":0.004584991,"domain_scores_codex":[0.998936,0.0005512475,0.00007246822,0.0002058314,0.00006611056,0.0001683469],"domain_scores_gemma":[0.9988461,0.0002858603,0.0003152261,0.0001178518,0.00005618658,0.0003788221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9883704,0.001430176,0.0008409194,0.0002896168,0.001495722,0.00001581297,0.00001913819,0.0003177339,0.0006152026,0.00006517096,0.0003368629,0.006203222],"study_design_scores_gemma":[0.9202222,0.06899451,0.00509529,0.00008614679,0.003466712,0.00003433071,0.00003998862,0.0006087153,0.0003455662,0.0002734092,0.0008054161,0.00002788007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870442,0.007277333,0.0004327815,0.0007778854,0.0006331505,0.0009255356,0.0009538421,0.0000604287,0.001894844],"genre_scores_gemma":[0.9896647,0.002491652,0.0006699589,0.0009208168,0.0005370099,0.001056696,0.001502536,0.00001883616,0.003137768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005253306,"threshold_uncertainty_score":0.01757407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0269477683234731,"score_gpt":0.3422365740486171,"score_spread":0.315288805725144,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}